Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

P1.16-13 Photo Dynamic Therapy (PDT) in Our Hospital

Journal of Thoracic Oncology

English

MA05.03 Immune Microenvironment and Its Association With Adjuvant Chemotherapy Benefit in Locoregionally Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology

English

MA10.03 Plasmatic Evaluation of the Intestinal Barrier and Blood Microbiota, and Antibiotic Use in Non-Small Cell Lung Cancer Patients Treated With Nivolumab

Journal of Thoracic Oncology

English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.12-04 a Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

P1.15-07 Geriatric Oncology - Lung Cancer in Elderly Patients and Palliative Treatment: Prospective Analysis of A. C. Camargo Cancer Center

Journal of Thoracic Oncology

English

P3.cr-22 Pulmonary Tuberculosis – A Chameleon; Mimicking Lung Cancer on Imaging

Journal of Thoracic Oncology

English

JCSE01.19 ALTER-0303 Study: Tumor Mutation Index (TMI) for Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line

Journal of Thoracic Oncology

English

MA23.06 Small Residual Setup Errors After Image-Guided Radiotherapy Affect Heart Dose and Are Linked to Overall Survival

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Respiratory Medicine

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

P1.16-13 Photo Dynamic Therapy (PDT) in Our Hospital

MA05.03 Immune Microenvironment and Its Association With Adjuvant Chemotherapy Benefit in Locoregionally Advanced Lung Adenocarcinoma

MA10.03 Plasmatic Evaluation of the Intestinal Barrier and Blood Microbiota, and Antibiotic Use in Non-Small Cell Lung Cancer Patients Treated With Nivolumab

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

P1.12-04 a Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

P1.15-07 Geriatric Oncology - Lung Cancer in Elderly Patients and Palliative Treatment: Prospective Analysis of A. C. Camargo Cancer Center

P3.cr-22 Pulmonary Tuberculosis – A Chameleon; Mimicking Lung Cancer on Imaging

JCSE01.19 ALTER-0303 Study: Tumor Mutation Index (TMI) for Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line

MA23.06 Small Residual Setup Errors After Image-Guided Radiotherapy Affect Heart Dose and Are Linked to Overall Survival